ENDOCRINE: Diabetes Concepts and Insulin Therapy 1 Flashcards
◦ Rapid Acting
a. insulin lispro (Humalog®), aspart (Novolog®), glulisine (Apidra®)
b. Regular insulin (Humulin R®/Novolin R®)
c. Neutral Protamine Hagedorn (NPH) insulin (Humulin N®)
d. insulin glargine (Lantus®)
nsulin detemir (Levemir®)
a. insulin lispro (Humalog®), aspart (Novolog®), glulisine (Apidra®)
Regular Acting
a. insulin lispro (Humalog®), aspart (Novolog®), glulisine (Apidra®)
b. Regular insulin (Humulin R®/Novolin R®)
c. Neutral Protamine Hagedorn (NPH) insulin (Humulin N®)
d. insulin glargine (Lantus®)
nsulin detemir (Levemir®)
b. Regular insulin (Humulin R®/Novolin R®)
Intermediate Acting
a. insulin lispro (Humalog®), aspart (Novolog®), glulisine (Apidra®)
b. Regular insulin (Humulin R®/Novolin R®)
c. Neutral Protamine Hagedorn (NPH) insulin (Humulin N®)
d. insulin glargine (Lantus®)
nsulin detemir (Levemir®)
c. Neutral Protamine Hagedorn (NPH) insulin (Humulin N®)
Long Acting
a. insulin lispro (Humalog®), aspart (Novolog®), glulisine (Apidra®)
b. Regular insulin (Humulin R®/Novolin R®)
c. Neutral Protamine Hagedorn (NPH) insulin (Humulin N®)
d. insulin glargine (Lantus®)
nsulin detemir (Levemir®)
d. insulin glargine (Lantus®) nsulin detemir (Levemir®)
- Excess glucose stored in liver and skeletal muscle tissue
* Glycogen or •Glycogenolysis
•Glycogen
- Conversion of glycogen into glucose when needed
* Glycogen or •Glycogenolysis or Insulin
•Glycogenolysis
Direct effect on fat metabolism
•Stimulates lipogenesis and inhibits lipolysis
•Stimulates protein synthesis
•Glycogen or •Glycogenolysis or Insulin
Insulin
•Promotes intracellular shift of potassium and magnesium
into the cells
•Glycogen or •Glycogenolysis or Insulin
Insulin
Fasting blood glucose goal for diabetic patients
of ? to ? mg/dL
70 to 130
•Caused by insulin deficiency and insulin resistance
Type 1
Type 2
Type 2
HbA1C of less than ?%
7
◦ Insulin therapy
Type 1
Type 2
Type 1
Lifestyle changes
◦ Oral drug therapy
◦ Insulin when the above no longer provide
glycemic contro
Type 1
Type 2
Type 2
USED TO TREAT: ◦ 1) Primarily for hyperglycemia ◦ type I and II diabetes ◦ 2) Can also use fast acting insulin for hyperkalemia
•Glycogen or •Glycogenolysis or Insulin
Insulin
Rapid-acting: Lispro insulin
◦ ONSET: ? to ? min
◦ PEAK: ? to ? hr
◦ DURATION: ? to ? hr
Rapid-acting: Lispro insulin
◦ ONSET: 15 to 30 min
◦ PEAK: 0.5 to 2.5 hr
◦ DURATION: 3 to 6 hr
Short-acting: Regular insulin
◦ ONSET: ? to ? hr
◦ PEAK: ? to ? hr
◦ DURATION: ? to ? hr
Short-acting: Regular insulin
◦ ONSET: 0.5 to 1 hr
◦ PEAK: 1 to 5 hr
◦ DURATION: 6 to 10 hr
Intermediate-acting: NPH insulin
• ONSET: ? to ? hr
• PEAK: ? to ? hr
• DURATION: ? to ? hr
Intermediate-acting: NPH insulin
• ONSET: 1 to 2 hr
• PEAK: 6 to 14 hr
• DURATION: 16 to 24 hr
Long-acting: Insulin glargine
• ONSET: ? min
• PEAK: ?
• DURATION: ? to ? hr
Long-acting: Insulin glargine
• ONSET: 70 min
• PEAK: None
• DURATION: 18 to 24 hr
Primary/Required: Blood Glucose!
◦ Hypoglycemia is defined as mg/dL
◦ Consider holding if (provider preference)
◦ Consider holding dose if patient not ?
Primary/Required: Blood Glucose!
◦ Hypoglycemia is defined as <70 mg/dL
◦ Consider holding if <130 (provider preference)
◦ Consider holding dose if patient not eating
Secondary: ◦ ?-We check this while patients are on IV DRIPS ◦ Hemoglobin A1C ◦ ? month average of glucose levels ◦ Goal %
Potassium-We check this while patients are on IV DRIPS
◦ Hemoglobin A1C
◦ 3 month average of glucose levels
◦ Goal <7%
◦ ? can be given as IV for emergency purposes
Insulin can be given as IV for emergency purposes
◦? insulin as IV push to treat hyperkalemia or critically high glucose
◦ Rapid insulin as IV push to treat hyperkalemia or critically high glucose